PAM
Private Asset Management’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-77,841
| Closed | -$711K | – | 148 |
|
|
2021
Q4 | $711K | Sell |
77,841
-59,014
| -43% | -$539K | 0.09% | 96 |
|
|
2021
Q3 | $1.46M | Sell |
136,855
-40,503
| -23% | -$433K | 0.2% | 72 |
|
|
2021
Q2 | $2.75M | Sell |
177,358
-15,495
| -8% | -$241K | 0.37% | 52 |
|
|
2021
Q1 | $3.13M | Buy |
192,853
+22,339
| +13% | +$362K | 0.44% | 50 |
|
|
2020
Q4 | $3.61M | Sell |
170,514
-510
| -0.3% | -$10.8K | 0.54% | 45 |
|
|
2020
Q3 | $2.54M | Buy |
171,024
+24,345
| +17% | +$361K | 0.42% | 49 |
|
|
2020
Q2 | $2.16M | Buy |
146,679
+15,789
| +12% | +$232K | 0.38% | 53 |
|
|
2020
Q1 | $1.54M | Buy |
130,890
+15,420
| +13% | +$181K | 0.32% | 59 |
|
|
2019
Q4 | $2.71M | Buy |
115,470
+14,870
| +15% | +$350K | 0.44% | 56 |
|
|
2019
Q3 | $1.86M | Buy |
100,600
+4,650
| +5% | +$86K | 0.32% | 64 |
|
|
2019
Q2 | $1.78M | Buy |
95,950
+3,495
| +4% | +$65K | 0.3% | 64 |
|
|
2019
Q1 | $2.26M | Sell |
92,455
-1,427
| -2% | -$34.9K | 0.4% | 59 |
|
|
2018
Q4 | $2.44M | Buy |
93,882
+2,625
| +3% | +$68.1K | 0.47% | 56 |
|
|
2018
Q3 | $2.89M | Sell |
91,257
-2,493
| -3% | -$78.9K | 0.45% | 59 |
|
|
2018
Q2 | $3.64M | Sell |
93,750
-1,350
| -1% | -$52.4K | 0.59% | 53 |
|
|
2018
Q1 | $2.63M | Buy |
95,100
+8,125
| +9% | +$224K | 0.45% | 54 |
|
|
2017
Q4 | $1.57M | Buy |
86,975
+57,050
| +191% | +$1.03M | 0.25% | 69 |
|
|
2017
Q3 | $483K | Buy |
+29,925
| New | +$483K | 0.08% | 101 |
|